↓ Skip to main content

Dove Medical Press

Article Metrics

Predicting high risk of exacerbations in bronchiectasis: the E-FACED score

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, January 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy
1 policy source
twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
87 Dimensions

Readers on

mendeley
65 Mendeley
Title
Predicting high risk of exacerbations in bronchiectasis: the E-FACED score
Published in
International Journal of Chronic Obstructive Pulmonary Disease, January 2017
DOI 10.2147/copd.s121943
Pubmed ID
Authors

Miguel Angel Martinez-Garcia, Rodrigo A Athanazio, Rosa Maria Girón, Luis Máiz-Carro, David de la Rosa, Casilda Olveira, Javier de Gracia, Montserrat Vendrell, Concepción Prados-Sánchez, Georgina Gramblicka, Mônica Corso Pereira, Fernando Lundgren, Mara Fernandes de Figuereido, Francisco Arancibia, Samia Z Rached

Abstract

Although the FACED score has demonstrated a great prognostic capacity in bronchiectasis, it does not include the number or severity of exacerbations as a separate variable, which is important in the natural history of these patients. Construction and external validation of a new index, the E-FACED, to evaluate the predictive capacity of exacerbations and mortality. The new score was constructed on the basis of the complete cohort for the construction of the original FACED score, while the external validation was undertaken with six cohorts from three countries (Brazil, Argentina, and Chile). The main outcome was the number of annual exacerbations/hospitalizations, with all-cause and respiratory-related deaths as the secondary outcomes. A statistical evaluation comprised the relative weight and ideal cut-off point for the number or severity of the exacerbations and was incorporated into the FACED score (E-FACED). The results obtained after the application of FACED and E-FACED were compared in both the cohorts. A total of 1,470 patients with bronchiectasis (819 from the construction cohorts and 651 from the external validation cohorts) were followed up for 5 years after diagnosis. The best cut-off point was at least two exacerbations in the previous year (two additional points), meaning that the E-FACED has nine points of growing severity. E-FACED presented an excellent prognostic capacity for exacerbations (areas under the receiver operating characteristic curve: 0.82 for at least two exacerbations in 1 year and 0.87 for at least one hospitalization in 1 year) that was statistically better than that of the FACED score (0.72 and 0.78, P<0.05, respectively). The predictive capacities for all-cause and respiratory mortality were 0.87 and 0.86, respectively, with both being similar to those of the FACED. E-FACED score significantly increases the FACED capacity to predict future yearly exacerbations while maintaining the score's simplicity and prognostic capacity for death.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Other 10 15%
Student > Ph. D. Student 9 14%
Student > Bachelor 9 14%
Student > Postgraduate 5 8%
Student > Master 5 8%
Other 15 23%
Unknown 12 18%
Readers by discipline Count As %
Medicine and Dentistry 39 60%
Biochemistry, Genetics and Molecular Biology 2 3%
Computer Science 1 2%
Nursing and Health Professions 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 5 8%
Unknown 16 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2018.
All research outputs
#4,459,732
of 16,135,689 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#552
of 1,881 outputs
Outputs of similar age
#109,270
of 361,152 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#25
of 80 outputs
Altmetric has tracked 16,135,689 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 1,881 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,152 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.